FDA Finds Morphine-Spiked Herbal Cough Syrup In Chinese Firm's Plant
This article was originally published in The Tan Sheet
The finding of morphine in a consumer health product made in China could rekindle concerns about lapses in supply chain security previously linked to drugs and adulterants or contaminants found in other imported FDA-regulated products.
You may also be interested in...
FDA says trace amounts of melamine found in U.S.-manufactured infant formula poses no danger, but the discovery will likely lead to a renewed push for food safety oversight and possibly for a separate food safety agency
The discovery of adulterated ingredients in imported prescription drugs will likely cause increased scrutiny of supply chain operations for other segments across the food and drug industries
Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain